(Yicai) Jan. 3 -- US pharmaceutical company Gilead Sciences has been given the greenlight by Chinese regulators to sell its ...

TCW Funds, an investment management company, released its “TCW Relative Value Large Cap Fund” Q3 2024 investor letter. A copy ...

TCW Relative Value Large Cap Fund highlighted stocks like Gilead Sciences, Inc. (NASDAQ:GILD), in the third quarter 2024 investor letter. Gilead Sciences, Inc. (NASDAQ:GILD) is a biopharmaceutical ...

BMO Capital analyst Evan Seigerman has maintained their neutral stance on MRK stock, giving a Hold rating on January 10.Stay Ahead of the ...

Vera Bradley faces shareholder pressure for underperformance, while acquisitions and restructurings define this week's deal ...

The dairy cow H5N1 has infected over 60 persons, but has caused milder disease than the genotype D1.1. Across the pond, in China, an epidemic of another ... Remdesivir is developed by Gilead. The ...

As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...

Cat owners in China desperate to save their beloved cats are using human ... Antiviral drugs like GS-441524, developed by ...

With cases of Feline Infectious Peritonitis (FIP) on rise in China, cat owners are making their pets pop in Covid-19 drugs as ...

The Chang'e-6 spacecraft drilled beneath the Moon's surface and returned with 2kg of rock and soil samples. These materials ...

The EU drugs regulator says Gilead Sciences’ antiviral drug remdesivir ... with the drug in COVID-19 – by a research team in China – is due to report findings shortly. Studies are also ...

When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...